Metagenomi Therapeutics: Q1 Earnings Snapshot

Published: 2026-05-11 16:20:13 ET MGX

Published on 05/11/2026 at 04:20 pm EDT

EMERYVILLE, Calif. (AP) — EMERYVILLE, Calif. (AP) — Metagenomi Therapeutics, Inc. (MGX) on Monday reported a loss of $23.1 million in its first quarter.

The Emeryville, California-based company said it had a loss of 61 cents per share.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MGX at https://www.zacks.com/ap/MGX

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News